secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001638833-24-000132
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q2 revenue +14.2% to $762.1M; raises FY2024 guidance
---------------------------------------------------------------------

- Revenue $762.1M (+14.2% YoY); same-facility revenue up 9.9%, cases up 3.9%.
- Adjusted EBITDA $118.3M (+18.1%); margin 15.5% (+50 bps).
- Net loss attributable to company $15.5M.
- FY2024 guidance raised: revenue >$3.075B, Adjusted EBITDA >$508M.
- Deployed ~$220M on acquisitions YTD; balance sheet refinanced and hedged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000132/0001638833-24-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000132/sgry-20240806.htm
  HTML page:      https://secwatch.observer/filing/0001638833-24-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer